DexCom Aktie
75,21USD | -1,06USD | -1,39% |
WKN: A0D9T1 / ISIN: US2521311074
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 98,71 |
Vanguard Group, Inc. (Subfiler) | 11,68 |
The Vanguard Group, Inc. | 11,38 |
Capital Research & Management Co. (Global Investors) | 4,60 |
State Street Corp. | 4,27 |
BlackRock Fund Advisors | 3,96 |
Baillie Gifford & Co. | 3,84 |
Vanguard Total Stock Market ETF | 3,26 |
Vanguard 500 Index Fund | 2,69 |
Sands Capital Management LLC | 2,64 |
Geode Capital Management LLC | 2,54 |
BlackRock Institutional Trust Co. NA | 2,23 |
Vanguard Mid Cap Index Fund | 2,17 |
Invesco QQQ Trust | 1,99 |
Capital Research & Management Co. (World Investors) | 1,95 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 5 200 | 6 400 | 6 300 | 7 600 | 9 600 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,28 | 0,30 | 0,39 | 0,38 | 0,38 |
Bilanz (in Mio. USD) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 1 969 | 3 425 | 3 684 | 3 669 | 4 426 |
Summe Anlagevermögen | 426 | 958 | 1 179 | 1 723 | 1 839 |
Summe Aktiva | 2 395 | 4 383 | 4 864 | 5 392 | 6 265 |
Bilanz (in Mio. USD) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 1 160 | 1 840 | 1 879 | 2 145 | 2 594 |
Summe Fremdkapital | 1 512 | 2 556 | 2 612 | 3 260 | 4 196 |
Summe Eigenkapital | 883 | 1 827 | 2 252 | 2 132 | 2 069 |
Summe Passiva | 2 395 | 4 383 | 4 864 | 5 392 | 6 265 |
Adresse
6340 Sequence Drive, 92121 San Diego | |
Telefon | +1 (858) 200-0200 |
Internet | http://www.dexcom.com |
Management
Barry J. Regan
Executive Vice President-Global Operations |
Bridgette P. Heller
Independent Director |
Donald M. Abbey
Executive VP-IT Quality & Regulatory Affairs |
Eric J. Topol
Independent Director |
Girish Naganathan
Chief Technology Officer & Executive VP |
Jacob S. Leach
Chief Operating Officer & Executive Vice President |
Jereme M Sylvain
Chief Financial Officer & Executive Vice President |
Karen M. Dahut
Independent Director |
Kevin Ronald Sayer
Chairman, President & Chief Executive Officer |
Kyle J. Malady
Independent Director |
Mark G. Foletta
Lead Independent Director |
Matt V. Dolan
Executive VP-Strategy & Corporate Development |
Michael Jon Brown
Chief Legal Officer & Executive Vice President |
Nicholas Augustinos
Independent Director |
Paul R. Flynn
Executive Vice President-Global Revenue |
Richard Alexander Collins
Independent Director |
Rimma Driscoll
Independent Director |
Sadie M Stern
Chief Human Resources Officer & Executive VP |
Sean Christensen
Vice President-Finance & Investor Relations |
Shelly R. Selvaraj
Chief Information Officer & Senior Vice President |
Steven R. Altman
Independent Director |
Steven Robert Pacelli
Executive VP & Managing Director-Dexcom Ventures |
Teri L. Lawver
Chief Commercial Officer & Executive VP |